Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3667

6 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3667). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Atorvastatinfigure1. (Atorvastatinfigure1)
Chemical structure of atorvastatin calcium, displaying detailed molecular arrangement including calcium ion complexation and hydration, consistent with the active ingredient atorvastatin calcium.*
FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

Atorvastatinfigure2. (Atorvastatinfigure2)
A line chart showing cumulative incidence percentages over approximately 3.5 years, comparing Atorvastatin to placebo. The chart tracks the increase in incidence, with Atorvastatin exhibiting a lower cumulative incidence than placebo. A hazard ratio (HR) with confidence interval and p-value is also displayed, indicating statistical comparison between the two groups.*
FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

Atorvastatinfigure3. (Atorvastatinfigure3)
A line chart depicting cumulative hazard percentage over a 5-year period comparing placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard percentage. Two lines show atorvastatin consistently lower than placebo, indicating a hazard ratio (HR) of 0.63 with a p-value of 0.001.*
FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

Atorvastatinfigure4. (Atorvastatinfigure4)
A Kaplan-Meier curve graph comparing the time to first major cardiovascular endpoint over 5 years for atorvastatin 10 mg and 80 mg doses. The y-axis shows the percentage of subjects experiencing the event, and the x-axis shows time in years. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value (0.0002), illustrating differences in event rates between the two dosages.*
FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

FDA Label Image

Pdp (68071 3667 3)

Pdp (68071 3667 3)
Atorvastatin Calcium 40 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The label shows the product name, strength, quantity (#30 tablets), NDC 68071-3667-3, and includes dosing information, storage instructions, and a lot number. Tablets are described as oval, biconvex with a debossed '40' on one side and 'A55' on the other.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.